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Background: Active warming during surgery prevents perioperative hypothermia but the 
effectiveness and post-operative infection rates may differ between warming technologies. We 
report results of a pilot study in patients over the age of 65 undergoing hemiarthroplasty 
following fractured neck of femur. 
 
Aim: To establish the recruitment and data management strategies needed for a full trial 
comparing post-operative infection rates associated with forced air versus resistive fabric 
warming.  
 
Methods: Participants were randomised 1:1 in permuted blocks to forced air or resistive fabric 
warming. Hypothermia was defined as a temperature of <36ºC at the end of surgery. Primary 
outcomes were the number of participants recruited and the number with definitive deep 
surgical site infections. 
 
Findings: 515 participants were randomised at 6 sites over a period of 18 months. Follow-up 
was completed for 70.1%. Thirty-seven participants were hypothermic (7.5% in the FAW 
group; 9.7 % in the RFW group). The mean temperatures before anaesthesia and at the end of 
surgery were similar. For the primary clinical outcome, there were 4 deep surgical site 
infections in the forced air warming group and 3 in the resistive fabric warming group. All 
participants who developed a post-operative infection had antibiotic prophylaxis, a cemented 
prosthesis and were operated under laminar airflow; none were hypothermic. There were no 
serious adverse events related to warming.  
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Conclusion: Surgical site infections were identified in both groups. Progression from the 
pilot to the full trial is possible but will need to take account of the high attrition rate. 
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All surgical patients are at risk of a wound infection and there are many factors that influence 
that risk following hip fracture surgery, including age, lifestyle, poor pre-fracture health status, 
frailty and previous infection [1]. Patients who develop a surgical site infection (SSI) have one-
year mortality at least three times that of patients who do not suffer post-operative infections 
[2]. Treatment for deep SSI doubles operative costs, triples investigation costs and quadruples 
ward costs [3].  
 
Following a landmark study by Lidwell et al. in 1982, which demonstrated a relative reduction 
of 61% in post-operative infection rate amongst patients undergoing total hip or knee 
replacement surgery [4], ultra clean laminar airflow (LAF) became common practice and was 
routinely installed into new-build orthopaedic operating theatres as a strategy to prevent 
infection. LAF is currently used in more than 60% of hospitals in the UK [5] but it is costly, 
there are reservations about its effectiveness in preventing infection [6-10], and there is some 
suggestion that it may even cause harm [10 11]. Despite limited evidence, an International 
Consensus meeting on prosthetic joint infections concluded that LAF is no longer considered 
necessary [12]. It is not currently recommended by the World Health Organization (WHO) 
[13] for reducing the risk of infection during arthroplasty surgery and it is no longer advised 
by some in new build operating theatres [7]. It is possible, however, that the type of warming 
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used may be influencing the protective effects of LAF [8] and, therefore, that such advice is 
premature [8 14]. 
 
A core temperature of 2°C below normal increases the incidence of wound infection three-fold 
[15]. Preventing inadvertent perioperative hypothermia (IPH) by patient warming not only 
reduces the rates of wound infection but also decreases morbidity and mortality [15-21] and is 
recommended by the National Institute for Health and Care Excellence (NICE) [22 23] for all 
operations on all high risk patients and those with operations lasting longer than 30 minutes. 
Several intraoperative warming methods exist [24] but a systematic review of 67 randomised 
controlled trials involving patient warming systems from 1964 to 2015, failed to identify which 
method is associated with the fewest post-operative complications [25]. Forced air warming 
(FAW), which warms the patient by convection, has historically been considered the most 
effective non-invasive method of transferring heat to the patient and is commonplace in 
orthopaedic surgery. This is despite growing concern that FAW may interfere with LAF [26].  
 
Mobilisation of non-sterile air from floor level [27], increased concentration of particles over 
the surgical site [28], elevated microbial counts in the operating theatre [29], and micro-
organisms found in both the hoses and blower systems [30-33], for example, could potentially 
be compromising the sterility of the surgical site. In addition, disruption of LAF by FAW has 
been shown in studies with neutral-buoyancy detergent bubbles [27 34],  high-fidelity 
predictive fluid flow simulations [35] and modelling of temperature gradients [36]. An 
International Consensus meeting discussed these issues but agreed there was no direct evidence 
to definitively link FAW with an increased risk of SSIs [12], similar to several reviews on this 
topic [37-40]. In the absence of a large-scale trial, therefore, this controversy is likely to remain 
unanswered. 
 
A single centre observational study over a 2.5-year period [27] found that the risk of developing 
deep SSI up to 60 days after surgery fell by over two thirds when FAW was replaced with an 
alternative method, resistive fabric warming (RFW), which warms patients by air-free 
conduction. This was a retrospective study prone to confounding due to a lack of control for 
antimicrobial prophylaxis before surgery and other risk factors for SSI. A well-conducted 
randomised controlled trial comparing post-operative infection rates associated with FAW and 
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RFW would be large, challenging and expensive. The pilot study reported here was carried out 





The methodological details summarised here have already been published in full [41]. The 
CONSORT checklist and flowchart are shown in Appendices A and B respectively. 
 
Objective and Outcomes 
The primary objective of the RIIiO pilot study was to establish the recruitment and data 
management strategies needed for a full trial to compare post-operative infection rates 
associated with FAW and RFW. As such, the primary outcomes of the pilot study were the 
number of participants recruited and the number of definitive deep SSIs. Occurrence of 
superficial SSI, IPH, length of hospital stay, patient-reported outcome measures (EQ-5D-5L) 
and serious adverse events (SAEs), including death, were secondary outcomes. 
 
Participants, Randomisation and Intervention 
Adults undergoing hemiarthroplasty following hip fracture were recruited between 3rd April 
2017 and 18th September 2018 from 6 NHS hospitals in England comprising a mixture of 
district general and large teaching hospitals. Prior to surgery, participants were randomised 1:1 
in permuted blocks to either FAW or RFW during surgery. Temperature was recorded at 
induction of anaesthesia, at 30 minute intervals during surgery, at the end of surgery and upon 
arrival in the recovery room. IPH was defined as a core temperature of <36ºC at the end of 
surgery, or, if this measurement was not available, either upon arrival in the recovery room or 
the last core temperature measured during surgery [41]. Data were housed in an established 
software package (MACRO), which was also used to execute the randomisation. Each site was 
expected to recruit a minimum of 2 participants a week; there was no maximum recruitment 
target. 
 
Assessments and Blinding 
Baseline assessments included (i) age, gender and BMI, (ii) the American Society of 
Anaesthesiologists (ASA) physical status classification, (iii) the use of antimicrobial 
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prophylaxis, immuno-suppressants and use of a cemented or un-cemented prosthesis, and (iv) 
comorbidities including a history of ischaemic heart disease, peripheral vascular disease, 
stroke, dementia, kidney disease/renal failure, diabetes mellitus, rheumatoid arthritis, systemic 
autoimmune disease, HIV, and active malignancy. A comorbidity index, with a maximum 
score of 11, was calculated from the sum of the number of comorbidities of each participant. 
The participants were followed-up for signs of deep SSI (the primary endpoint) at 30 (± 7) days 
and 90 (± 14) days after surgery and superficial SSI (a secondary endpoint) at 30 (± 7) days. 
Definitions of deep and superficial SSI were adapted from the Centers for Disease Control 
surgical site infection criteria published in January 2016 [42]. Clinic attendance, re-admission 
to hospital, or return to theatre post-randomisation with signs and symptoms at the site of 
surgery were considered potential primary endpoints. To limit bias, the potential primary 
endpoints were assessed by an independent endpoint review committee who were blinded to 
the randomised allocation. 
 
Statistical Analysis 
Normally distributed continuous variables were summarised by means and standard deviations, 
skewed continuous variables by medians and interquartile ranges and categorical variables by 
frequencies and percentages. The EQ-5D-5L index value was calculated using the Stata 
command eq5dmap [43], the approach recommended by NICE [44]. All analyses were 
performed in Stata 15.1 (StataCorp. 2017. Stata Statistical Software: Release 15. College 





Recruitment and Retention 
Six hundred and thirty-four patients were assessed for eligibility, of which 515 were 
randomised to either FAW (n=255) or RFW (n=260). Figure 1 shows the progress of the 
randomised patients through the trial in a CONSORT diagram, reflecting the numbers 
theoretically available for analysis based on consent [45]. Table I shows the distribution of 
recruitment by site. Overall, the average recruitment rate was 1.9 participants per week per site 
and follow-up was completed for 70.1% of the randomised participants. Twenty-eight 
 7 
randomised participants (5.4%) did not receive their allocated warming technology. Six 
participants who were randomised to FAW (2.4%) received RFW and 22 participants 
randomised to RFW (8.5%) received FAW. Ninety-three participants (18.1%) were withdrawn 
from the study; reasons for withdrawal are given in Table SI. Twenty-eight of the withdrawn 
participants (30.1%) either had a surgical procedure other than hemiarthroplasty or no surgery 
at all. Most patients (443/515; 86.0%) were recruited under consultee consent; 117/515 
participants (22.7%) did not consent to follow-up and 54/515 participants (10.5%) died before 
follow-up could be completed. 
 
Baseline and Surgical Characteristics 
The baseline and surgical characteristics of the participants by randomisation group are shown 
in Table II.  The average age was 85.2 years (SD 7.5). The majority of participants were ASA 
grade III. There were almost twice as many females (n=293) as males (n=150). The mean BMI 
was similar for the two groups. Use of immuno-suppressants was recorded for a minority of 
participants (n=18). For participants for whom relevant data were available, 252/349 (72.2%) 
had one or more comorbidity. One third of randomised participants had dementia; diabetes 
mellitus, ischaemic heart disease and stroke were the next most frequent comorbidities, as 
shown in Table SII. Laminar flow ventilation was recorded as used for 435 of 465 participants 
who underwent surgery (93.6%). Use of antimicrobial prophylaxis before surgery was recorded 
for 432 participants (92.9%) and insertion of an antibiotic-loaded cemented prosthesis for 350 
participants (75.3%). 
 
Primary Endpoint Deep SSIs and Secondary Endpoint Superficial SSIs 
The primary endpoint was identification of a deep SSI within 90 days of surgery. Superficial 
SSI identified within 30 days of surgery was a secondary endpoint. Endpoint data were missing 
in 26 and 28 patients in the FAW and RFW arms respectively at 90 days and in 21 and 14 
patients at 30 days. 
   
Deep SSI occurred in 4/223 (1.8%) participants randomised to FAW and in 3/221 (1.4%) 
randomised to RFW (Table III). All deep SSIs were confirmed as ‘definite’ by an independent 
blinded endpoint review committee. Overall, the deep SSI rate was 1.6% of those with data 
available. Superficial SSI occurred in 7/201 (3.5%) in the FAW group and in 1/207 (0.5%) in 
the RFW group within 30 days of surgery, as determined by the local principal investigators.   
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Of the 15 infected participants in total, 8 were female (2 deep; 6 superficial) and 6 were male 
(5 deep; 2 superficial). All of the participants that developed an infection were operated on 
under LAF, received antibiotic prophylaxis and had a cemented prosthesis. Two of the 
participants who developed infections were receiving immuno-suppressants (1 deep SSI and 1 
superficial SSI). 
 
Secondary Endpoint IPH 
All recruitment sites used BairHugger (from Arizant Healthcare Inc, a 3MTM company) for 
their method of FAW. Either âUniqueTemp° (from Gerathermâ) or the Alpha Patient 
Warming System (from Inditherm Medical or Inspiration Healthcare) was used as the type of 
RFW. Thirty-seven participants in total were classed as hypothermic (temperature <36°C) at 
the last available temperature measurement; 16/213 (7.5%) participants in the FAW group and 
21/217 (9.7 %) in the RFW group. None of the hypothermic participants developed a post-
operative infection. The mean temperatures before anaesthesia (36.7°C for the FAW group 
(n=199) and 36.8°C for the RFW group [n=202]) and at the end of surgery (36.7°C for the 
FAW group [n=153] and 36.5°C for the RFW group [n=168]) were similar between the two 
groups, as shown in Table SIII.  
 
Other Secondary Endpoints 
The mean duration of surgery and the median length of hospital stay were similar between the 
two groups (Table SIV), as were the patient reported outcome measures for quality of life 
(Table SV). There were 121 SAEs reported in the FAW group and 102 SAEs reported in the 
RFW group. Most SAEs required new or prolongation of existing hospitalisation or resulted in 
death, as shown in Table SVI. None of the SAEs recorded were related to the trial interventions. 
A total of 73 participants died; of those included in the final analysis, 39/457 (8.5%) died within 






Whether or not FAW and RFW are equally effective at preventing IPH is debatable. As recently 
reviewed by Ackermann et al. [40], there are many studies that claim RFW is as effective as 
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FAW whilst others have shown that the incidence of IPH is higher with RFW and rates of re-
warming are slower than FAW [46]. In our study, the number of hypothermic patients for the 
two groups and the mean temperatures at the end of surgery were similar, suggesting that FAW 
and RFW are both effective. 
 
Baseline data collected in our study included the most widely recognised risk factors for SSI 
in this population, including age, ASA score, BMI and comorbidities. Patients showed similar 
demographics to previous studies [47 48] although a higher proportion were comorbid as 
compared to a study by Roche et al. [49]. As a result of the randomisation process, reported 
risk factors were evenly distributed between the groups in our study (Table II).    
 
Definitive infections were confirmed in both groups and for both sexes. Deep SSI rates in the 
literature range from as low as 0.7% [50] to as high as 5.1% [51]. Such variation may be due 
to differences in recording, classification and definition and because few studies report deep 
SSI as a primary outcome [52]. No statistical comparison of the number of infections with 
FAW versus RFW can be made from these pilot data but a potential disparity between deep 
and superficial SSIs reinforces the need for clearly defined criteria. The study was designed on 
the basis of an anticipated 2.5% event rate. The observed event rate for deep SSI (1.6%) was 
lower than expected but as there were only a small number of deep SSIs, there is not enough 
evidence to indicate that the expected event rate was substantially greater than the observed 
rate.  
 
Recruitment to the trial was more difficult than anticipated with only half of the sites reaching 
the expected target. The progression rule from the pilot study to the full trial included a 
projected recruitment of 100 participants per year or two participants per week at each pilot 
site [41]. The overall average recruitment rate was close at 1.9 participants per site per week. 
There were fewer hemiarthroplasties than anticipated at the start of the study and fewer 
resources than expected at some of the sites. Recruitment was greatest in the large teaching 
hospitals but retention was greatest in a small general hospital. Eligible patients who were not 
randomised were most frequently missed due to the nature of the emergency setting (e.g. 
weekend operations, altered surgery schedules etc.). Poor communication was the main reason 
why 28 randomised participants did not receive their allocated warming technology. In addition 
to the emergency setting mandating a need for a two-step consent process, the high average 
 10 
age of the participants and the frequency of dementia may have contributed to the higher than 
expected withdrawal rate. There were also a substantial number of deaths before follow-up 
could be completed. Such high attrition needs to be accounted for in the sample size calculation 
for a full trial of the same design. 
 
This pilot study has demonstrated that, keeping the same trial design (i.e. detecting an absolute 
difference in infection rate of 1%, with 90% power and a 5% significance level) and allowing 
for 25% - 30% attrition, a full trial will require 10 788 - 11 219 participants. This would involve 
either a large number of recruitment sites, a prolonged recruitment period or adoption by an 




To date, more than 200 million patients have been warmed by the 3MTM Bair Hugger system 
despite theoretical concerns that it may be associated with a risk of post-operative surgical site 
infection. Although alternative systems are available, FAW is likely to continue as the market 
leader. This study found no safety concerns with either FAW or RFW and they were both 
similarly effective at maintaining normothermia. Definitive SSIs were identified with both 
FAW and RFW. A very large, multi-centre superiority trial is required to determine which 
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at 30 days 
Number 
followed up 
at 90 days 
Queen Elizabeth The Queen Mother Hospital a 109 (21.2%) 33 3.3 91 (83.5%) 76 (69.7%) 71 (65.1%) 
Heartlands Hospital b 104 (20.2%) 44 2.4 102 (98.1%) 71 (68.3%) 64 (61.5%) 
Princess Royal Hospital c 99 (19.2%) 53 1.9 83 (83.8%) 69 (69.7%) 73 (73.7%) 
Milton Keynes University Hospital 75 (14.6%) 50 1.5 67 (89.3%) 60 (80.0%) 58 (77.3%) 
Northumbria Specialist Emergency Care Hospital d 70 (13.6%) 52 1.4 68 (97.1%) 54 (77.1%) 54 (77.1%) 
Horton General Hospital e 58 (11.3%) 67 0.9 58 (100%) 57 (98.3%) 56 (96.6%) 
Total 515  1.9 469 (91.1%) 387 (75.1%) 376 (73.0%) 
a East Kent; b Birmingham; c Brighton; d Cramlington; e Banbury
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 Mean SD n Mean SD n Mean SD n 
Age (years) 85.3 7.5 221 85.0 7.4 222 85.2 7.5 443 
Height (m) 1.6 0.1 174 1.6 0.1 181 1.6 0.1 355 
Weight (kg) 63.9 15.8 172 63.8 15.3 182 63.8 15.5 354 
BMI (kg/m2) 23.7 4.8 167 23.6 4.8 176 23.6 4.8 343 
 n % n % n % 
Gender       
Female 137 62.0 156 70.3 293 66.1 
Male 84 38.0 66 29.7 150 33.9 
ASA Physical Status       
ASA II 31 14.2 36 16.4 67 15.3 
ASA III 142 64.8 147 67.1 289 66.0 
ASA IV 45 20.5 36 16.4 81 18.5 
ASA V 1 0.5 0 0.0 1 0.2 
Immuno-
suppressants       
No 211 95.9 213 95.9 424 95.9 
Yesb 9 4.1 9 4.1 18 4.1 




   
0 47 28.0 50 27.6 97 27.8 
1 58 34.5 76 42.0 134 38.4 
2 42 25.0 35 19.3 77 22.1 
3 17 10.1 15 8.3 32 9.2 
4 4 2.4 3 1.7 7 2.0 








No 3 1.4 4 1.8 7 1.6 








Cemented Prosthesis d 170 76.9 180 81.1 350 79.0 
Un-cemented 
Prosthesis 









No 8 3.6 1 0.5 9 2.0 
Yes e 212 96.4 220 99.5 432 98.0 
a Analysis followed intention to treat principles in this pilot study; participants were analysed in the group they 
were randomised to, regardless of the procedure they actually received. 
b Recorded immuno-suppressants included Prednisolone/systemic steroid therapy and Methotrexate 
c Comorbidity score is a sum of the number of comorbidities of each participant. Maximum score was 11. 
d Including Palacos, Simplex, Copal, Optipac 





Table III: Number of definitive SSIs (primary endpoints) and recorded superficial SSIs 
(secondary endpoints) by allocated intervention for participants with complete data 
 
Forced Air Warming Resistive Fabric Warming Overall 
Deep SSI by 30 days a 2 2 4 
Deep SSI by 90 days a 2 1 3 
Superficial SSI by 30 
days b 
7 1 8 
Total 11 4 15 
a Confirmed as ‘definite’ by an independent blinded endpoint review committee on the basis of symptoms of infection, repeat surgery, 
radiological evidence, deep tissue histology and culture results 
b Determined by the local principal investigator on the basis of symptoms of infection, if the wound was opened and if a secondary specimen 
















Figure 1. CONSORT flow diagram, extension to randomised pilot and feasibility studies, 
showing the number of patients and their flow through the trial from screening for eligibility 
to analysis. 
 
